Jersey's Cannabis Reclassification Diverges From Mainland UK Law

September 15, 2026

Photo via Pexels.

Type "Jersey cannabis law" into a search engine and you will get a fair number of results about marijuana dispensaries in American cities that share the name. That's not this Jersey. The one in question sits in the English Channel, fourteen miles off the coast of Normandy, a self-governing jurisdiction with its own parliament, its own courts, and its own criminal statute book entirely separate from the one Westminster administers for the UK mainland. It has no representation in the UK Parliament and no obligation to follow British drug law at all, which is precisely why it's been able to quietly rewrite its own.

Over the course of 2025, Jersey's States Assembly reclassified cannabis oil from Class A to Class B, then did the same for cannabinol and cannabinol derivatives before the year was out. Neither move touched cannabis or cannabis resin themselves, which stay at Class B, matching the mainland UK tier. But both were real, substantive shifts in sentencing exposure, and both happened without a single vote in London.

Then came something considerably bigger. Proposition P.116/2025, lodged by Health Minister Deputy Tom Binet in December 2025, asked the Assembly to end prosecution for personal possession and cultivation and to explore a state-run trial of non-medical cannabis sales. It was scheduled for debate in February 2026. It never happened. The proposition got pushed past Jersey's June 2026 general election, leaving a reform with 81% public support in a 2025 consultation of 2,063 islanders sitting in legislative limbo, while neighboring Guernsey now starts building a working group of its own.

Not New Jersey: A Bailiwick With Its Own Drug Law

Photo via Pexels.

Jersey belongs to a small category of places that are British in flag and monarchy but not British in law. It answers to the Crown directly rather than to the UK government, and its legislature -- the States Assembly, made up of elected Members and Connétables from the island's parishes -- passes its own primary legislation covering everything from tax to criminal justice. Westminster handles Jersey's foreign affairs and defense; it does not write Jersey's drug law.

For decades that distinction didn't matter much in practice, because Jersey chose to mirror the UK's Misuse of Drugs Act almost exactly, adopting the same three-tier Class A, B and C structure and largely the same substance placements. Mirroring isn't the same as being bound, though, and that gap is exactly where the current reform movement lives. Jersey can reclassify a substance, decriminalize a quantity threshold, or authorize a government cannabis trial entirely on its own initiative, with no need for a Westminster bill, a Home Office consultation, or a nod from the Advisory Council on the Misuse of Drugs.

Contrast that with the rest of the UK, which operates under the same national classification schedule -- meaning any change to how cannabis, cannabinol, or cannabis oil are treated elsewhere in Britain has to clear the UK Parliament, a body with 650 competing constituencies and considerably less appetite for drug reform than a Channel Islands legislature with roughly 49 members total.

None of this has anything to do with the American state after which the island is sometimes confused, a mix-up common enough that Jersey's own government communications occasionally have to clarify it. New Jersey legalized recreational cannabis sales under an entirely separate US federal-state system. The Bailiwick of Jersey shares nothing with it beyond a name traced back to the same Norman-French roots -- no shared legislature, no shared court system, no shared drug schedule, nothing.

The Reclassifications Already on the Books

Jersey reclassified several cannabis-related substances—including cannabis oil and cannabinol derivatives—from Class A to the less severe Class B during 2025, aligning them with cannabis/resin's existing classification.

The first crack in Jersey's mirrored drug schedule came through cannabis oil. A States Member worked with the advocacy group End Cannabis Prohibition Jersey to attach an amendment to Deputy Coles's Proposition P.31/2024, and when the Assembly adopted it, cannabis oil moved from Class A -- the tier reserved for heroin and cocaine -- down to Class B, the tier cannabis itself already occupied. That change took legal effect in 2025.

Cannabinol and cannabinol derivatives followed the same path before the end of the year, dropping from Class A to Class B as well. Cannabis and cannabis resin, notably, never needed reclassifying in the first place -- they'd sat at Class B in Jersey all along, matching the mainland UK tier, so those two changes were specifically about closing an odd inconsistency where a cannabis extract or a related compound could carry a heavier legal classification, and correspondingly heavier sentencing exposure, than the plant material itself.

That inconsistency was not a technicality to anyone actually charged under it. Class A offences in Jersey carry substantially harsher maximum penalties than Class B, and a possession or supply charge involving cannabis oil under the old schedule could theoretically expose someone to sentencing in the same range as a cocaine charge, even though the psychoactive substance involved was chemically continuous with a Class B product. Fixing that gap didn't touch the island's underlying prohibition on cannabis, and it didn't decriminalize anything for ordinary users -- possessing cannabis oil or cannabinol derivatives is still a criminal matter in Jersey. But it removed a real sentencing cliff-edge that campaigners had flagged as disproportionate.

End Cannabis Prohibition Jersey has been the engine behind both amendments, working the Assembly's committee process rather than pushing for a referendum or a public campaign alone. That approach -- finding a sympathetic States Member, attaching precise legal language to an existing proposition, and building a voting majority one amendment at a time -- is a template ECPJ has clearly been refining, and it's the same groundwork that fed into the far larger proposition that followed in December 2025.

P.116/2025: The Proposal That Almost Changed Everything

Photo by Neon Wang via Unsplash.

P.116/2025 arrived with a title that undersold its ambition: Future approach to personal cannabis use in Jersey. Lodged au Greffe -- the formal filing process for States propositions -- by Health Minister Deputy Tom Binet on 19 December 2025, it didn't ask the Assembly to legalize anything outright. Instead it asked Members to direct the Minister for Health and Social Services to go away and draft actual implementation plans for ending prosecution of personal possession and cultivation involving small quantities, reframing the whole matter as a public health issue rather than a criminal one.

The proposition went further than decriminalization alone. It also proposed repealing or amending a set of related offences, subject to specified quantity thresholds still to be worked out, and -- most strikingly -- floated trialing a government-controlled production and sale scheme for non-medical cannabis. That last piece would have put Jersey in genuinely rare company: a jurisdiction within the British Isles running a state-operated adult-use cannabis retail trial, something neither the UK government nor any of the other nearby island jurisdictions has attempted.

The Assembly set 3 February 2026 as the earliest date to debate it. Had that debate gone ahead and passed, Jersey would have leapt past most of its neighbors on cannabis policy, closer in spirit to jurisdictions like Malta or parts of Germany than to the rest of the UK, where personal possession remains a criminal offence enforced through police discretion and cannabis warnings rather than any formal decriminalization statute.

It's worth being precise about what P.116/2025 actually was, though: a request for a plan, not the plan itself. Passing it would have instructed the Health Minister to come back to the Assembly with detailed proposals -- draft legislation, thresholds, a retail model -- for a further vote down the line. It was a green light to start drafting, the preparatory step before the actual legal architecture, rather than a bill that itself rewrote Jersey's criminal code the moment it passed.

Why the Debate Got Shelved

Photo by planet_fox via Pixabay.

The 3 February 2026 debate never happened. Binet's three reform strands -- ending prosecution for personal possession and cultivation, amending related offences, and trialing state-run non-medical sales -- were pulled from the order paper and deferred until after Jersey's next general election, effective immediately shelving the most significant drug policy proposal the island had seen in years.

That election landed on 7 June 2026, and its mere presence on the calendar was enough to freeze the legislative clock. Jersey's States Assembly, like most small-jurisdiction legislatures facing a full electoral turnover, tends to avoid launching contentious, high-profile social policy debates in the run-up to a vote, on the logic that a proposition passed by an outgoing Assembly can be immediately deprioritized or reopened by an incoming one anyway. Better, in this reading, to let a new Assembly take ownership of the decision from the start.

End Cannabis Prohibition Jersey doesn't see it that way. The group has argued publicly that the Council of Ministers should bring P.116/2025 back to the Assembly floor early in the new term rather than allow it to lapse quietly through inaction -- a real risk for any proposition that loses its momentum once the Member who lodged it, in this case Binet, may no longer hold the same ministerial portfolio or even the same Assembly seat post-election.

This kind of election-driven stall isn't unique to cannabis policy or to Jersey specifically -- small jurisdictions with compact legislatures often see contentious propositions reshuffled or dropped entirely when committee assignments and ministerial portfolios turn over. What makes this case notable is the scale of what's on hold: a proposal that would have ended personal cannabis prosecution and trialed state cannabis sales, with no confirmed new debate date as of now, sitting in a queue that a newly elected Assembly may or may not choose to prioritize.

The Public Wants Reform -- and So Does Guernsey

The numbers behind this push are hard to wave away. The public consultation tied to Deputy Coles's P.31/2024 ran through the summer of 2025 and pulled in 2,063 validated responses -- a substantial sample for an island with a population under 110,000. Of those respondents, 81% favored some form of cannabis reform. For a jurisdiction whose drug law has historically tracked the UK's cautious Class A/B/C framework almost line for line, that's not a marginal preference -- it's a lopsided mandate that any incoming Assembly will have a hard time ignoring outright, even if it chooses to slow-walk the specifics.

Jersey isn't the only Channel Island paying attention. In January 2026, a Guernsey deputy lodged a requete -- the formal mechanism Guernsey's States Assembly uses to compel government action -- calling for a cross-Committee working group to examine regulatory options for cannabis. Guernsey has historically moved even more cautiously than Jersey on drug policy, so a formal working group proposal there suggests the reform conversation happening in St Helier isn't staying contained to one island.

Taken together, this puts the Channel Islands in an increasingly distinct position relative to Westminster. Both Jersey and Guernsey remain tied to the UK through the Crown and share deep roots in English common law tradition, yet both are now actively exploring cannabis frameworks well beyond anything currently on the table in Parliament, where cannabis remains firmly Class B with no serious legislative push toward decriminalization or state sales.

Not everything is moving, though. A promised report on the state of Jersey's medicinal cannabis sector, expected by the end of 2025, hasn't materialized. And cultivation regulations referenced in the Cabinet Office's 2025-2026 Legislation Programme remain without a confirmed timeframe. Reform in Jersey, in other words, is real but uneven -- some pieces moving with genuine speed, others sitting exactly where they were a year ago.

What Jersey's last eighteen months demonstrate is a fairly simple structural point: a small jurisdiction that fully controls its own law can move on drug policy at a pace no part of mainland UK can currently match, because it isn't waiting on 650 MPs to agree on anything. Two Class A-to-B reclassifications landed with comparatively little fuss in 2025. A far more ambitious proposition got as far as a scheduled Assembly debate within weeks of being lodged. That's a genuinely different velocity than Westminster's, where cannabis rescheduling debates have circled for years without resolution.

But the same compactness that lets reform move fast also lets it stall fast, and that's exactly what happened here. One election calendar was enough to knock P.116/2025 off the agenda entirely, with no debate held and no rescheduled date set. The real test now sits with the Assembly elected on 7 June 2026: whether the Council of Ministers puts Binet's proposition back on the order paper early in the new term, as ECPJ is pushing for, or whether a reform proposal with 81% public backing simply expires unattended while other legislative priorities take precedence.

Guernsey's working group is worth watching in parallel, because if it produces actual regulatory recommendations, the Channel Islands could end up with three distinct cannabis regimes operating within a few dozen miles of each other -- Jersey's, Guernsey's, and mainland UK's -- each shaped by a different legislature moving at a different speed, bound together by little more than a shared monarch and a lot of overlapping tourist traffic.